Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

Are you feeling out of breath while talking or climbing stairs These silent symptoms may be the first signs of COPD that one ...

Coughing can be caused by pollution or viral infections. Experts explain key differences, warning signs and when simple care ...

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...

For over 60 years, the search for an effective pharmacologic treatment for refractory or unexplained chronic cough has been ...

Misunderstanding COPD and asthma can be risky. Recognising the difference in the condition, treatment options, and the need for early intervention is important.

AN AMBULANCE stopped to refuel on the way to a dying man who was struggling to breathe despite having almost half a tank of ...

The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.

CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...

Local health care providers say if you’re showing signs of a respiratory illness, you must wear a mask in area urgent cares ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...